A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma

Clinical trial NCT04735575 · TERMINATED

Trial details

NCT number: NCT04735575
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory Multiple Myeloma

Start date: 2021-05-20
Primary completion: 2024-08-20
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.